
    
      Prospective, single center, single arm pilot study enrolling up to 12 patients at a single
      investigational site in the netherlands. Patients meeting eligibility criteria for TAVR and
      none of the exclusion criteria will be enrolled to receive the Embolic Deflection Device
      throughout the duration of the TAVR procedure.
    
  